ADH7 and gastric adenocarcinoma: ADH7 showed promise as a prognostic biomarker and chemotherapy target for gastric adenocarcinoma, with low ADH7 expression and is related to the prognosis of patients with better histological types of adenocarcinoma and squamous cell carcinoma [41].